Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

Details for Australian Patent Application No. 2009253683 (hide)

Owner ONCOLYTICS BIOTECH INC.

Inventors Coffey, Matthew C.; Thompson, Bradley G.; Pandha, Hardev

Agent Griffith Hack

Pub. Number AU-A-2009253683

PCT Pub. Number WO2009/143611

Priority 61/056,292 27.05.08 US; 61/113,791 12.11.08 US

Filing date 27 May 2009

Wipo publication date 3 December 2009

International Classifications

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/143611 Priority application(s): WO2009/143611

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253692-Method and device for the detection of microsleep events

2009253682-Modulating interstitial pressure and oncolytic viral delivery and distribution